|
|
||||||||
Published online before print September 12, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
,
,
,
*Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, Naples, Italy; and
Istituto di Endocrinologia ed Oncologia Sperimentale, Napoli, Italy
@ To whom correspondence should be addressed. E-mail: racioppi{at}unina.it.
| Abstract |
|---|
The ability of the envelope glycoprotein gp120 [human immunodeficiency virus (HIV) env] to induce intracellular signals is thought to contribute to HIV-1 pathogenesis. In the present study, we found that the exposure of CD4+ CD45RA+ naive T cells to HIVenv results in a long-lasting hyporesponsiveness to antigen stimulation. This phenomenon is not dependent on CD4-mediated signals and also can be generated by the exposure of naive T cell-to-soluble-CD4-HIVenv complexes. The analysis of the proximal signaling reveals that HIVenv does not activate Lck as well as the mitogen-activated protein kinase intermediate cascade. Conversely, the envelope glycoprotein stimulates the cyclic adenosine monophosphate (cAMP)-dependent protein kinase A (PKA) activity and induces the progressive accumulation of the phosphorylated form of the cAMP-responsive element binding. Of note, the ligation of CXCR4 by stromal cell-derived factor-1
but not the engagement of CD4 by monoclonal antibody stimulates the PKA activity and induces a long-lasting hyporesponsivity state in naive CD4+ lymphocytes. The pretreatment of lymphocytes with H89, a cell-permeable PKA inhibitor, prevents the induction of anergy. These findings reveal a novel mechanism by which HIVenv may modulate the processes of clonal expansion, homeostatic proliferation, and terminal differentiation of the naive T lymphocyte subset.
Key Words: CXCR4 HIVenv cAMP CREB
This article has been cited by other articles:
![]() |
B. Harmon and L. Ratner Induction of the G{alpha}q Signaling Cascade by the Human Immunodeficiency Virus Envelope Is Required for Virus Entry J. Virol., September 15, 2008; 82(18): 9191 - 9205. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hajishengallis, M. Wang, S. Liang, M. Triantafilou, and K. Triantafilou Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function PNAS, September 9, 2008; 105(36): 13532 - 13537. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bostik, E. S. Noble, S. T. Stephenson, F. Villinger, and A. A. Ansari CD4+ T Cells from Simian Immunodeficiency Virus Disease-Resistant Sooty Mangabeys Produce More IL-2 Than Cells from Disease-Susceptible Species: Involvement of p300 and CREB at the Proximal IL-2 Promoter in IL-2 Up-Regulation J. Immunol., June 15, 2007; 178(12): 7720 - 7729. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liang, M. Wang, K. Triantafilou, M. Triantafilou, H. F. Nawar, M. W. Russell, T. D. Connell, and G. Hajishengallis The A Subunit of Type IIb Enterotoxin (LT-IIb) Suppresses the Proinflammatory Potential of the B Subunit and Its Ability to Recruit and Interact with TLR2 J. Immunol., April 15, 2007; 178(8): 4811 - 4819. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fernando, H. Hu, H. Ni, J. A. Hoxie, and D. Weissman Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses Blood, March 15, 2007; 109(6): 2538 - 2544. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Martinelli, C. Cicala, D. Van Ryk, D. J. Goode, K. Macleod, J. Arthos, and A. S. Fauci HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells PNAS, February 27, 2007; 104(9): 3396 - 3401. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Giordano, D. M. Magaletti, and E. A. Clark Nitric oxide and cGMP protein kinase (cGK) regulate dendritic-cell migration toward the lymph-node-directing chemokine CCL19 Blood, February 15, 2006; 107(4): 1537 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-A. Amella, B. Sherry, D. H. Shepp, and H. Schmidtmayerova Macrophage Inflammatory Protein 1{alpha} Inhibits Postentry Steps of Human Immunodeficiency Virus Type 1 Infection via Suppression of Intracellular Cyclic AMP J. Virol., May 1, 2005; 79(9): 5625 - 5631. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |